Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Avadel Pharmaceuticals PLC (NASDAQ:AVDL)

8.68
Delayed Data
As of Dec 15
 0.00 / 0.00%
Today’s Change
7.52
Today|||52-Week Range
12.30
-16.46%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues41.7M51.2M47.5M42.5M
 
 
 
 
 
Cost of Goods Sold2.5M3.5M4.5M3.5M
 
 
 
 
 
Depreciation And Amortization2.8M816.6K793.5K1.1M
 
 
 
 
 
 
Operating ExpensesGross Income36.3M46.9M42.2M37.8M
 
 
 
 
 
General Expenses23.4M18.6M19.7M21.0M
 
 
 
 
 
Research And Development13.0M7.0M7.0M8.7M
 
 
 
 
 
Total Operating Expenses28.7M22.9M25.0M25.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income12.9M28.3M22.5M16.8M
 
 
 
 
 
Extraordinary Credit3.6M6.8M13.6M11.2M
 
 
 
 
 
Extraordinary Charge0.00-2.6M-1.1M0.00
 
 
 
Interest Expense On Debt252.4K256.6K269.6K281.6K
 
 
 
 
 
Other Expenses1.2M1.3M2.5M1.9M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income17.5M33.6M37.2M29.6M
 
 
 
 
 
Income Taxes-12.9M-8.3M-7.6M-6.3M
 
 
 
 
 
Net Income4.6M25.3M29.7M23.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS41.3M41.4M41.1M40.1M
 
 
 
 
 
Shares To Calculate EPS Diluted42.8M42.8M42.5M41.3M
 
 
 
 
 
 
Earnings Per ShareEPS$0.11$0.61$0.72$0.58
 
 
 
 
 
EPS Diluted$0.11$0.60$0.70$0.56